2010
DOI: 10.1089/adt.2009.0212
|View full text |Cite
|
Sign up to set email alerts
|

Multiplexed Random Peptide Library and Phospho-Specific Antibodies Facilitate Human Polo-Like Kinase 1 Inhibitor Screen

Abstract: ABBREVIATIONS: % CV, percentage coeffi cient of variation; APC, allophycocyanin; b-FKD, biotinylated FKD peptide; DELFIA ® , dissociation-enhanced lanthanide fl uorescence immunoassay; b-ASFA, biotinylated ASFA peptide; DMSO, dimethyl sulfoxide; Eu-p(S/T)F Ab, anti-phosphor-(S/T)F antibody labeled with europium-chelate;FI, fl uorescence intensity; HTS, high-throughput screening; HPV16, human papillomavirus type 16; IC 50 , a half-maximal inhibitory concentration; mean + 3 std, the assay mean plus 3 times the s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2011
2011
2012
2012

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 42 publications
(57 reference statements)
0
2
0
Order By: Relevance
“…The most extensively used VS methods are docking [11], pharmacophore [12], quantitative structure activity relationship (QSAR) [2,3,13], similarity searching [5], and machine learning [14]. These methods are often divided into structure-based virtual screening (SBVS) and ligand-based virtual screening (LBVS) depending on what is already known about a target and its ligands Fig.…”
Section: Brief Overview Of Extensive Used Virtual Screening Methodsmentioning
confidence: 99%
“…The most extensively used VS methods are docking [11], pharmacophore [12], quantitative structure activity relationship (QSAR) [2,3,13], similarity searching [5], and machine learning [14]. These methods are often divided into structure-based virtual screening (SBVS) and ligand-based virtual screening (LBVS) depending on what is already known about a target and its ligands Fig.…”
Section: Brief Overview Of Extensive Used Virtual Screening Methodsmentioning
confidence: 99%
“…Non-radiometric based platforms, measuring 1) phosphorylated product such as ELISAs, 10 time-resolved fluorometry (DELFIA™), 11 time-resolved fluorescence resonance energy transfer (TR-FRET), 12,13 and fluorescence polarization (FP), 14 or 2) ATP consumption such as kinetic coupled assays, 15 and luminescence-based assays, 16 have been developed and successfully implemented in many screening laboratories. The former platform relies on specific anti-phosphopeptide antibodies and/or the correct peptide sequence for the substrate.…”
Section: Introductionmentioning
confidence: 99%